News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
732,686 Results
Type
Article (52772)
Company Profile (389)
Press Release (679525)
Section
Business (213710)
Career Advice (2130)
Deals (37013)
Drug Delivery (107)
Drug Development (85968)
Employer Resources (172)
FDA (16908)
Job Trends (15612)
News (363276)
Policy (34912)
Tag
Academia (2767)
Alliances (52495)
Alzheimer's disease (1297)
Approvals (16843)
Artificial intelligence (162)
Bankruptcy (367)
Best Places to Work (11915)
Biotechnology (263)
Breast cancer (200)
Cancer (1452)
Cardiovascular disease (118)
Career advice (1786)
Cell therapy (299)
Clinical research (68487)
Collaboration (498)
Compensation (260)
COVID-19 (2706)
C-suite (112)
Data (1406)
Diabetes (175)
Diagnostics (6471)
Earnings (87339)
Employer resources (150)
Events (115839)
Executive appointments (396)
FDA (17580)
Funding (438)
Gene therapy (209)
GLP-1 (645)
Government (4633)
Healthcare (19504)
Infectious disease (2803)
Inflammatory bowel disease (117)
Interviews (329)
IPO (16813)
Job creations (4111)
Job search strategy (1523)
Layoffs (457)
Legal (8561)
Lung cancer (218)
Manufacturing (220)
Medical device (13496)
Medtech (13501)
Mergers & acquisitions (20338)
Metabolic disorders (472)
Neuroscience (1630)
NextGen Class of 2024 (6859)
Non-profit (4744)
Northern California (1702)
Obesity (268)
Opinion (220)
Patents (121)
People (59418)
Pharmaceutical (103)
Phase I (21233)
Phase II (29973)
Phase III (22533)
Pipeline (519)
Postmarket research (2965)
Preclinical (9218)
Radiopharmaceuticals (253)
Rare diseases (274)
Real estate (6357)
Regulatory (23217)
Research institute (2507)
Resumes & cover letters (364)
Southern California (1471)
Startups (3831)
United States (15442)
Vaccines (637)
Weight loss (200)
Date
Today (131)
Last 7 days (579)
Last 30 days (2605)
Last 365 days (36551)
2024 (36049)
2023 (41352)
2022 (52669)
2021 (57248)
2020 (55782)
2019 (48594)
2018 (36789)
2017 (34133)
2016 (33843)
2015 (39745)
2014 (33706)
2013 (29119)
2012 (31264)
2011 (31925)
2010 (30263)
Location
Africa (837)
Arizona (208)
Asia (42113)
Australia (6931)
California (3854)
Canada (1444)
China (313)
Colorado (175)
Connecticut (182)
Europe (91669)
Florida (534)
Georgia (134)
Illinois (398)
Indiana (233)
Maryland (649)
Massachusetts (3027)
Michigan (173)
Minnesota (294)
New Jersey (1119)
New York (1086)
North Carolina (777)
Northern California (1702)
Ohio (145)
Pennsylvania (930)
South America (1210)
Southern California (1471)
Texas (556)
Utah (108)
Washington State (410)
732,686 Results for "cancer prevention pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
BioMidwest
Calviri Announces Completion of Groundbreaking Preventative Canine Cancer Vaccine Trial
Calviri, Inc. announced the successful conclusion of the Vaccine Against Canine Cancer Study on May 4, 2024; a five-year clinical trial investigating a novel preventative cancer vaccine in dogs.
June 3, 2024
·
4 min read
Cancer
Cancer Pipelines Shrink as Incyte, iTeos Cut Candidates Following Disappointing Data
Incyte is abandoning its ALK2 blocker zilurgisertib, which it was trialing for myelofibrosis-associated anemia, while iTeos will deprioritize the development of inupadenant after it failed to meet the biotech’s clinical bar in a Phase II study of metastatic non-small cell lung cancer.
December 13, 2024
·
2 min read
·
Tristan Manalac
Press Releases
A2A Pharmaceuticals, Inc. Announces Phase 1 Clinical Trial Advancements in TACC3 Inhibition Program Targeting Multiple Cancers
December 12, 2024
·
2 min read
Policy
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Various Solid Cancer
MediciNova, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 for the prevention of metastasis in various cancers including pancreatic cancer, lung cancer, breast cancer, colorectal cancer, melanoma, and ovarian cancer.
June 5, 2024
·
5 min read
Press Releases
In five cancer types, prevention and screening have been major contributors to saving lives
December 5, 2024
·
5 min read
Biotech Beach
MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
MediciNova, Inc. announced that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a pending patent application which covers MN-166 for the prevention of metastasis of eye cancer.
May 20, 2024
·
6 min read
Press Releases
Bexion Pharmaceuticals, Inc. Announces Poster Presentation at the Society for Immunotherapy of Cancer (SITC) 39th Annual Meeting
November 5, 2024
·
2 min read
Press Releases
Marker Therapeutics Awarded $9.5 Million Grant from the Cancer Prevention & Research Institute of Texas (CPRIT) to Support the Investigation of MT-601 in Patients with Pancreatic Cancer
December 18, 2024
·
7 min read
Pharm Country
Perseus Therapeutics Announces Development of TSLP Antibody for Prevention of Hair Loss in Cancer Patients and Treatment of Inflammatory Diseases with well-known CRO partner
Perseus Therapeutics, a pioneering biopharmaceutical company based in New York City, is proud to announce the development of a novel thymic stromal lymphopoietin (TSLP) antibody aimed at preventing hair loss in cancer patients and treating a range of inflammatory diseases, including asthma.
May 22, 2024
·
2 min read
Press Releases
Citius Pharmaceuticals, Inc. and Citius Oncology, Inc. Announce Promising Preliminary Results of an Investigator-Initiated Phase I Clinical Trial of Pembrolizumab (KEYTRUDA®) and LYMPHIR™ in Cancer Patients with Recurrent Solid Tumors
November 11, 2024
·
18 min read
1 of 73,269
Next
